Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Matza

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Rheumatic Diseases Clinics of North America|October 17, 2024
Imaging Challenges and Developments in Large-vessel VasculitisMark A Matza, Ana B Arevalo, Sebastian Unizony
Arthritis Care & Research|September 22, 2020
ReplyMark A Matza, Ana D Fernandes, John H Stone, et al.
Arthritis Care & Research|April 6, 2020
Ustekinumab for the Treatment of Giant Cell ArteritisMark A Matza, Ana D Fernandes, John H Stone, et al.
Arthritis Care & Research|November 8, 2020
ReplyMark A Matza, Ana D Fernandes, John H Stone, et al.
The Lancet. Rheumatology|January 22, 2024
Treatment for giant cell arteritis with 8 weeks of prednisone in combination with tocilizumab: a single-arm, open-label, proof-of-concept studySebastian Unizony, Mark A Matza, Adam Jarvie, et al.
RMD Open|April 6, 2023
Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritisMark A Matza, Nicholas Dagincourt, Shalini V Mohan, et al.
The New England Journal of Medicine|April 20, 2022
Case 12-2022: A 41-Year-Old Woman with Transient Ischemic Attack and Mitral Valve MassesMark A Matza, Sandra P Rincon, Evin Yucel, et al.
The Lancet. Rheumatology|April 15, 2022
Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept studyMark A Matza, Cory A Perugino, Liam Harvey, et al.
Circulation. Cardiovascular Imaging|November 19, 2024
Current and Emerging Approaches to Imaging Large Vessel VasculitisAhmed Tawakol, Brittany Nicole Weber, Michael T Osborne, et al.
The New England Journal of Medicine|October 21, 2020
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19John H Stone, Matthew J Frigault, Naomi J Serling-Boyd, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Rheumatic Diseases Clinics of North America|October 17, 2024
Imaging Challenges and Developments in Large-vessel VasculitisMark A Matza, Ana B Arevalo, Sebastian Unizony
Arthritis Care & Research|September 22, 2020
ReplyMark A Matza, Ana D Fernandes, John H Stone, et al.
Arthritis Care & Research|April 6, 2020
Ustekinumab for the Treatment of Giant Cell ArteritisMark A Matza, Ana D Fernandes, John H Stone, et al.
Arthritis Care & Research|November 8, 2020
ReplyMark A Matza, Ana D Fernandes, John H Stone, et al.
The Lancet. Rheumatology|January 22, 2024
Treatment for giant cell arteritis with 8 weeks of prednisone in combination with tocilizumab: a single-arm, open-label, proof-of-concept studySebastian Unizony, Mark A Matza, Adam Jarvie, et al.
RMD Open|April 6, 2023
Outcomes during and after long-term tocilizumab treatment in patients with giant cell arteritisMark A Matza, Nicholas Dagincourt, Shalini V Mohan, et al.
The New England Journal of Medicine|April 20, 2022
Case 12-2022: A 41-Year-Old Woman with Transient Ischemic Attack and Mitral Valve MassesMark A Matza, Sandra P Rincon, Evin Yucel, et al.
The Lancet. Rheumatology|April 15, 2022
Abatacept in IgG4-related disease: a prospective, open-label, single-arm, single-centre, proof-of-concept studyMark A Matza, Cory A Perugino, Liam Harvey, et al.
Circulation. Cardiovascular Imaging|November 19, 2024
Current and Emerging Approaches to Imaging Large Vessel VasculitisAhmed Tawakol, Brittany Nicole Weber, Michael T Osborne, et al.
The New England Journal of Medicine|October 21, 2020
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19John H Stone, Matthew J Frigault, Naomi J Serling-Boyd, et al.
Pageof 1